The current study aims to scrutinize the expression of CLPTM1L in cervical cancer tissues and cells, delving deeper into its potential biological role in the pathogenesis of cervical cancer and its impact on the sensitivity of cervical cancer cells to cisplatin. The gene discussed is CLPTM1L; the disease is cervical carcinoma.